Article Information
History
- May 7, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Hinta Meijerink, PhD1,*,
- Elisabeth H. Madslien, PhD2,3,
- Camilla Mauroy, MSc2,
- Mia Karoline Johansen2,
- Sindre Møgster Braaten, MSc4,
- Christine Ursin Steen Lunde, MSc5,
- Trude Margrete Arnesen, PhD1,
- Siri Laura Feruglio, PhD2 and
- Karin Nygård, PhD2
- 1Department of infectious diseases and vaccines, Norwegian Institute of Public Health, Norway
- 2Department of infectious diseases and prevention, Norwegian Institute of Public Health, Norway
- 3Norwegian Defence Research Establishment (FFI), Norway
- 4Department of IT Systems Bergen, Norwegian Institute of Public Health, Norway
- 5Center for Test and Quality Assurance at Norwegian Health Network, Norsk Helsenett SF, Trondheim, Norway
- ↵*Corresponding author:
Hinta Meijerink, hinta.meijerink{at}fhi.no